CPHI stock · TECH stock

CPHI vs TECH

China Pharma Holdings Inc (CPHI) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.

China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.

Bio-Techne Corp (TECH) is a biotechnology company listed on US.

Latest reported CPHI revenue for 2024-12-31 was $4.5M. Net income was -$4.7M. Revenue was down 35.4% from 2023-12-31 to 2024-12-31. CPHI currently screens at market cap $29.0M.

Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.

CPHI currently screens at market cap $29.0M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.

Not investment advice. Open the CPHI and TECH stock pages for the full models.

Not investment advice.

Popular Stock Comparisons